Colon Care
Natural health product licensed in Canada
- Licence holder
- Advanced Genomics Gateway Inc.
- NPN or DIN-HM
- 80086933
- Status
- Active licence
- Licence date
- 9 July 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Aloe ferox Mill.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Senna alexandrina Mill.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Frangula purshiana Cooper: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes ainsi qu'une mention déconseillant l'usage prolongé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Rhamnus cathartica L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes ainsi qu'une mention déconseillant l'usage prolongé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Triacylglycérol lipase Source : Aspergillus niger - En entier Potency : 37.5 milligramme | 150 FCC LU | Not calculated |
| Citrus paradisi Source : Fruit Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 50 milligramme | 12.5 milligramme | Not calculated |
| Vaccinium macrocarpon Source : Fruit | 25 milligramme | Not calculated |
| Aloe ferox Source : Feuille | 75 milligramme | Not calculated |
| Juglans cinerea Source : Écorce âgée | 12.5 milligramme | Not calculated |
| Scutellaria lateriflora Source : Feuille | 17.5 milligramme | Not calculated |
| Juglans nigra Source : Fruit Hull | 50 milligramme | Not calculated |
| Mentha x piperita Source : Feuille | 37.5 milligramme | Not calculated |
| Zingiber officinale Source : Racine Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 1,000 milligramme Potency : 5 % Total gingerols and shogaols | 50 milligramme | Not calculated |
| Réglisse déglycyrrhizinée Source : Glycyrrhizae group - Racine Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 2,000 milligramme | 100 milligramme | Not calculated |
| L-Glutamine Source : L-Glutamine | 37.5 milligramme | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier Potency : 37.5 milligramme | 2,000 Unités d'alpha-amylase dextrinifiante du FCC | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier Potency : 37.5 milligramme | 2,000 Unités d'hémoglobine basées sur la tyrosine, du FCC | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma reesei - en entier Potency : 12.5 milligramme | 350 FCC CU | Not calculated |
| Plantago ovata Source : Enveloppe | 50 milligramme | Not calculated |
| Senna alexandrina Source : Feuille | 25 milligramme | Not calculated |
| Frangula purshiana Source : Écorce âgée | 15 milligramme | Not calculated |
| Capsicum annuum Source : Fruit | 7.5 milligramme | Not calculated |
| Silybum marianum Source : Graine(s) | 37.5 milligramme | Not calculated |
| Rheum undulatum Source : Racine | 25 milligramme | Not calculated |
| Trigonella foenum-graecum Source : Graine(s) | 11 milligramme | Not calculated |
| Rhamnus cathartica Source : Écorce âgée | 10 milligramme | Not calculated |
| Ulmus rubra Source : Écorce âgée | 12.5 milligramme | Not calculated |
| Calcium Source : Phosphate de calcium, dibasique | 5 milligramme | 10,000 µg |
Non-medicinal ingredients
Hypromellose, Gomme arabique (acacia), Fructooligosaccharides, Stéarate de magnésium, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 1 day |
Uses authorised in Canada
Supports the process of a colon cleanse by relieving occasional constipation. Short-term relief of occasional constipation. Promotes bowel movement by direct action in the intestine. A stimulant laxative. Source of antioxidant(s)/Provides antioxidant(s). Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Digestive enzyme. Digestive aid. Helps digest proteins. Helps support intestinal/gastrointestinal health. Could promote a favorable gut flora. May improve symptoms of bloating and abdominal pain resulting from intestinal gas symptoms.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have gallstones. Consult a health care practitioner prior to use if you have anaemia. Consult a health care practitioner prior to use if you are following a low protein diet. Consult a health care practitioner immediately if you experience chest pain, vomiting, or difficulty in swallowing or breathing after taking this product. Consult a health care practitioner prior to use if you are taking medications which inhibit peristaltic movement (e.g. opioids, loperamide). Consult a health care practitioner prior to use if you have symptoms such as abdominal pain, nausea, vomiting or fever (as these could be signs of abnormal constrictions of the gastrointestinal tract, diseases of the oesophagus and/or the superior opening of the stomach (cardia), potential or existing intestinal blockage, paralysis of the intestine, megacolon, faecal impaction, inflamed bowel or appendicitis). Consult a health care practitioner prior to use if you are taking thiazide diuretics, corticosteroids, licorice root or other medications or health products which may aggravate electrolyte imbalance. Consult a health care practitioner prior to use if you have a kidney disorder or are taking cardiac medications such as cardiac glycosides or antiarrhythmic medications. Consult a health care practitioner prior to use if you have faecal impaction or symptoms such as abdominal pain, nausea, vomiting or fever. Reduce dose or discontinue use if you experience abdominal pain, cramps, spasms and/or diarrhoea. If you have stomach ulcers or inflammation, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you have diabetes. Consult a health care practitioner prior to use if you are taking blood thinners . Consult a health care practitioner prior to use if you have a history of kidney stones. If you are taking any prescription medication, consult a health care practitioner prior to use. If you have a gastrointestinal lesion/ulcer, are taking an anticoagulant/ blood thinner or an anti-inflammatory, or are having surgery, consult a health care practitioner prior to use. If you have fever, vomiting, bloody diarrhoea or severe abdominal pain, consult a health care practitioner prior to use. If symptoms of digestive upset (e.g. diarrhea) occur, worsen, or persist beyond 3 days, discontinue use and consult a health care practitioner. Keep out of the reach of children. If overdose or accidental ingestion occurs, call a Poison Control Center immediately.
- Effets indésirables connus
Hypersensitivity, such as allergy, has been known to occur following inhaled and/or ingested psyllium; in which case, discontinue use. May cause temporary gas and/or bloating. Do not use if you have abnormal constrictions of the gastrointestinal tract, potential or existing intestinal blockage, atonic bowel, appendicitis, inflammatory colon disease such as Crohn's disease or ulcerative colitis, abdominal pain of unknown origin, undiagnosed rectal bleeding, severe dehydration with depleted water or electrolytes or diarrhoea.
- Contre-indications
Do not use if you are experiencing a sudden change in bowel habits that has persisted for more than 2 weeks, undiagnosed rectal bleeding, or failure to defaecate following the use of another laxative product. Do not use if you have diabetes mellitus in which blood sugar is difficult to regulate. Do not use if you have difficulty swallowing. Do not use if you have abnormal constrictions of the gastrointestinal tract, potential or existing intestinal blockage, atonic bowel, appendicitis, inflammatory colon disease (e.g. Crohn's disease or ulcerative colitis), abdominal pain of unknown origin, undiagnosed rectal bleeding, severe dehydration with depleted water or electrolytes, hemorrhoids or diarrhoea. If you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment), do not use this product. Do not use if you are pregnant or breastfeeding.
Source
Official Health Canada record, licence 80086933
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.